about us

With the global benefits of the new science of nanomedicine growing each year, the British Society for Nanomedicine has been created to allow open access for industry, academia, clinicians and the public to news and details of ongoing research throughout the UK.

As a registered charity (Charity number 1151497) our mission includes the direct explanation of the ongoing science and commercial developments to allow the public to understand and stay in touch with this exciting area as it impacts future global healthcare. Scientists can also present their latest advances and highlight their work to industry and other researchers.

The Society is affiliated to other leading organisations involved with nanomedicine including :  CLINAM, the European Technology Platform for Nanomedicine, the British Pharmacological Society and the American Society for Nanomedicine. For these and other important partnerships see our Links page.

You are welcome to join the Society through our membership page and we would be happy to hear your comments and about ways in which you want to be involved with the BSNM.

We would also like to acknowledge initial funding to create the Society from the Engineering and Physical Sciences Research Council

Steve Conlan is Professor of Molecular and Cell Biology and director the Centre for Nano Health at Swansea University Medical School . He is also head of the Reproductive Biology and Gynaecological Oncology research group, and Head of Enterprise and Innovation for the Medical School.

Tom McDonald is a Senior Lecturer in Nanomedicine at the University of Liverpool. His research is focussed on the design and synthesis of drug delivery systems.

“Hello, and a very warm welcome to the British Society of Nanomedicine. We are honoured to be appointed as the Co-Chairs of the Board of Trustees of BSNM and would like to take this opportunity to thank Andrew Owen and Steve Rannard for all of their hard work, commitment and leadership over the last 10 years!

We are delighted that Andrew and Steve will remain active in the Society moving forward.

One of our first actions as Chairs is to host a series of early career researcher events building on the success of the annual events that have been held around the UK over the past 10 years. The first of these will take place online on November 25^th and 26^th and will provide an opportunity for early career researchers to showcase innovative research and discuss outputs and opportunities with other researchers and experts in the field of nanomedicine (click here for more information and registration). We and all the other BSNM Trustees look forward to seeing you there.

Another new development is the partnership we are setting up with the journal of Precision Nanomedicine (PRNANO). This new journal is also sponsored by CLINAM and endorsed by the European Society for Nanomedicine. We look forward to working with PRNANO over the coming years. Details of the journal will appear on the website soon.

We look forward to working with you our members in the coming months as we continue to promote and share research ideas and enable collaborations that will benefit the nanomedicine community in UK and beyond.”